Testing effectiveness (Phase 2)WithdrawnNCT05312021
What this trial is testing
Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction
Who this might be right for
Heart Failure With Preserved Ejection Fraction
Cardurion Pharmaceuticals, Inc.